Xavier Brazzolotto
Bretigny, 91220, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and Butyrylcholinesterase for the Modulation of Neuroinflammation and Cognitive Dysfunction.
Journal: Journal of medicinal chemistry
Published: May 06, 2026
Leveraging multitargeting BChE-MAO B inhibitors against microglia-related neuroinflammation: in vitro biological evaluation, structure-activity relationships, drug-like properties, and X-ray crystal complexes.
Journal: European journal of medicinal chemistry
Published: April 23, 2026
Rational Design and Evaluation of Rivastigmine-Based Pleiotropic Prodrugs for the Treatment of Alzheimer's Disease.
Journal: ACS chemical neuroscience
Published: April 13, 2026
Combining β2-AR agonism with butyrylcholinesterase inhibition, a synergistic neuroprotective action against Alzheimer's disease.
Journal: RSC medicinal chemistry
Published: March 30, 2026
Access to novel potent pleiotropic prodrugs, targeting both butyrylcholinesterase and serotonin reuptake, with anti-amnesic activities in Alzheimer's disease model.
Journal: European journal of medicinal chemistry
Published: January 15, 2026
Integrative structural and kinetic analysis of the molecular basis for reduced carbamate inhibition in atypical butyrylcholinesterase.
Journal: Chemico-biological interactions
Published: November 07, 2025
Dual cholinergic modulation in dementia: Quinuclidine carbamates targeting butyrylcholinesterase and α7 nicotinic receptor.
Journal: Chemico-biological interactions
Published: September 18, 2025
Targeting Neuroinflammation and Cognitive Decline: First-in-Class Dual Butyrylcholinesterase and p38α Mitogen-Activated Protein Kinase Inhibitors.
Journal: Journal of medicinal chemistry
Published: August 08, 2025
The product of Ellman's reaction inhibits cholinesterases.
Journal: Protein science : a publication of the Protein Society
Published: July 21, 2025
N-Propargylpyrrolidine-based butyrylcholinesterase and monoamine oxidase inhibitors.
Journal: Chemico-biological interactions
Published: June 30, 2025
Challenges and advances in the development of antidotes against A-series nerve agents.
Journal: Archives of toxicology
Published: June 24, 2025
Expanding the reactive chemistry toolbox - warhead screening for covalent butyrylcholinesterase inhibitors.
Journal: Chemico-biological interactions
Published: June 17, 2025
Last Updated: 09/26/2026